Rising Biosciences (OTC: RBII)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Rising Biosciences (OTCEM: RBII) through any online brokerage.
There are no as such competitors for Rising Biosciences.
The latest price target for Rising Biosciences (OTCEM: RBII) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting RBII to rise to within 12 months (a possible 399999900.00% upside). 50 analyst firms have reported ratings in the last year.
The stock price for Rising Biosciences (OTCEM: RBII) is $0.000001 last updated June 30, 2022, 6:20 PM UTC.
The next Rising Biosciences (RBII) dividend date is projected to be Thursday, September 1, 2022.
Rising Biosciences’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Rising Biosciences.
Rising Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.